NCT02363920

Brief Summary

Nasal High Oxygen Flow (HOF) has been demonstrated to reduce the re-intubation rate in hypoxic patients and ameliorate breathing pattern in hypercapnic patients. The aim of this study is to better understand the physiological mechanism underlying these results, assessing the respiratory mechanics in stable hypercapnic COPD patients.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
14

participants targeted

Target at below P25 for phase_4

Timeline
Completed

Started Mar 2015

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

February 3, 2015

Completed
13 days until next milestone

First Posted

Study publicly available on registry

February 16, 2015

Completed
13 days until next milestone

Study Start

First participant enrolled

March 1, 2015

Completed
1.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 1, 2016

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

September 1, 2016

Completed
Last Updated

October 11, 2016

Status Verified

October 1, 2016

Enrollment Period

1.5 years

First QC Date

February 3, 2015

Last Update Submit

October 8, 2016

Conditions

Keywords

COPD patients

Outcome Measures

Primary Outcomes (1)

  • recording of respiratory mechanics

    Respiratory mechanics will be assessed using Mead and Wittenberger's technique.

    30 minutes per arm

Secondary Outcomes (1)

  • dyspnea score

    30 minutes per arm

Study Arms (4)

spontaneous breathing trial

PLACEBO COMPARATOR

the patients will be asked to breathe spontaneously using their acutal low oxygen flow

Device: HOFDevice: noninvasive mechanical ventilation (NIV)

HOF20

ACTIVE COMPARATOR

the patients will be asked to breathe with HOF of 20 L/min

Device: HOFDevice: noninvasive mechanical ventilation (NIV)

HOF30

ACTIVE COMPARATOR

the patients will be asked to breathe with HOF of 30 L/min

Device: HOFDevice: noninvasive mechanical ventilation (NIV)

noninvasive mechanical ventilation (NIV)

ACTIVE COMPARATOR

the patients will be asked to breathe with the support of a ventilator via a oro-nasal interface

Device: HOFDevice: noninvasive mechanical ventilation (NIV)

Interventions

HOFDEVICE

the addition of high oxygen flow to patients breathing spontaneously

HOF20HOF30noninvasive mechanical ventilation (NIV)spontaneous breathing trial

the addition of a ventilatory support delivered with a oro-nasal interface

HOF20HOF30noninvasive mechanical ventilation (NIV)spontaneous breathing trial

Eligibility Criteria

Age18 Years - 85 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • COPD patients
  • Chronic hypercapnic respiratory failure (pH\>7.34 and PaCO2\>45 mmHg)

You may not qualify if:

  • Cancer
  • Neurological and cardiac disease

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

San'Orsola Malpighi Hospital, Bologna ITALY

Bologna, 40138, Italy

Location

Related Publications (1)

  • Pisani L, Fasano L, Corcione N, Comellini V, Musti MA, Brandao M, Bottone D, Calderini E, Navalesi P, Nava S. Change in pulmonary mechanics and the effect on breathing pattern of high flow oxygen therapy in stable hypercapnic COPD. Thorax. 2017 Apr;72(4):373-375. doi: 10.1136/thoraxjnl-2016-209673. Epub 2017 Jan 19.

MeSH Terms

Conditions

Pulmonary Disease, Chronic Obstructive

Condition Hierarchy (Ancestors)

Lung Diseases, ObstructiveLung DiseasesRespiratory Tract DiseasesChronic DiseaseDisease AttributesPathologic ProcessesPathological Conditions, Signs and Symptoms

Study Officials

  • stefano nava, md

    Sant'Orsola Malpighi Hospital

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
phase 4
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Chief of Respiratory and Critical care Unit

Study Record Dates

First Submitted

February 3, 2015

First Posted

February 16, 2015

Study Start

March 1, 2015

Primary Completion

September 1, 2016

Study Completion

September 1, 2016

Last Updated

October 11, 2016

Record last verified: 2016-10

Locations